The CSDDD Omnibus I rollback mirrors the enforcement struggles of France’s eight-year-old Loi de Vigilance. As the UK watches from the sidelines, cross-border companies face a patchwork of due diligence rules that may produce more confusion than accountability.
Hugo Rindel (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: